Olga Shpilevskaya

Olga Shpilevskaya is an experienced finance professional with a strong background in clinical finance and accounting within the biotechnology and pharmaceutical sectors. Currently serving as Associate Director of Clinical Finance & FP&A at Iovance Biotherapeutics, Inc., Olga focuses on preparing annual clinical trial budgets, forecasts, and variance analysis, as well as designing financial models for clinical trials. Previous roles include Senior Accounting Manager at Adverum Biotechnologies, Inc., and Senior Accounting Manager at Gynesonics Inc., where responsibilities encompassed managing month-end closing processes, developing budget templates, and implementing accounting policies. Additional experience includes positions at Coherus BioSciences, Zenverge Inc., MAP Pharmaceuticals, and VE&E California, highlighting expertise in clinical trial reconciliations, revenue recognition, and general accounting functions. Olga holds a Master of Science degree in Computer Science/Engineering from Belarusian National Technical University and has completed various accounting and finance programs, including an Enrolled Agent designation from the IRS.